Comments*

 
  • Genetics & Genomics

  • Events 

    Friday, September 16, 2016 | 8:30 AM - 6:00 PM

    Big Data, Consumer Technology, and the Obesity Epidemic: Emerging Science and Ethical Considerations

    Speakers: Lori B. Andrews (Illinois Institute of Technology Chicago), Gary Bennett (Duke University), Barbara E. Millen (Millennium Prevention, Inc.), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael K. Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)

    Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?

    Thursday, September 22, 2016 | 8:00 AM - 2:15 PM

    Understanding Autophagy to Enhance Clinical Discovery: The 2016 Dr. Paul Janssen Award Symposium

    Featuring: Yoshinori Ohsumi (Tokyo Institute of Technology)

    The 2016 Dr. Paul Janssen Award Symposium will honor Dr. Yoshinori Ohsumi for his groundbreaking research demonstrating that autophagy is a crucial process in maintaining cellular homeostasis as well as establishing its role human health.

    Monday, October 3, 2016 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Marcin Imielinski (Weill Cornell Medicine), Christopher Lima (Memorial Sloan Kettering Cancer Center), Barry Sleckman (Weill Cornell Medicine), Alexandra Zidovska (New York University)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Thursday, November 10, 2016 | 8:00 AM - 6:00 PM

    Epigenetics in Cancer: Translational Medicine Approaches

    Speakers: Iannis Aifantis (NYU School of Medicine), Emily Bernstein (Icahn School of Medicine at Mount Sinai), Ryan Kruger (GlaxoSmithKline), Ross L. Levine (Memorial Sloan Kettering Cancer Center), Sheng Li (Weill Cornell Medical College), Christopher E. Mason (Weill Cornell Medicine), Kornelia Polyak (Dana Farber Cancer Institute, Harvard Medical School), Tim Somervaille (The University of Manchester), and Jorge DiMartino (Celgene)

    This conference will explore novel target and validation strategies, translational approaches to assess predictive and response biomarkers, resistance mechanisms, and combination strategies for targeting epigenetic susceptibilities in cancer.

    Friday, December 2, 2016 | 12:30 PM - 6:30 PM

    Aging and Nutrition: Novel Approaches and Techniques

    Speakers: Jan van Deursen (The Mayo Clinic), Vadim Gladyshev (Harvard University), Steven Horvath (University of California Los Angeles), Matt Kaeberlein (University of Washington), Vera Gorbunova (University of Rochester), and Arlan Richardson (University of Oklahoma)

    To explore the interplay between aging, nutrition, and metabolism, as well as the important role that novel technologies will play in current and future studies, we are bringing together several preeminent researchers in these fields.

  • Past Events

    Wednesday, July 13, 2016 | 9:00 AM - 5:00 PM

    MicroRNAs: A Gene Silencing Mechanism with Therapeutic Implications

    Keynote Speaker: David Bartel (Whitehead/MIT/HHMI)
    Speakers: Paul Grint (Regulus Therapeutics), David S Hong (The University of Texas MD Anderson Cancer Center ), Daniel J Siegwart (University of Texas Southwestern Medical Center), Frank Slack (BIDMC Cancer Center/Harvard Medical School), James W Welsh (The University of Texas MD Anderson Cancer Center)

    miRNAs play critical roles in regulating gene expression. This symposium will present up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.

    Monday, June 6, 2016 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Keynote Speaker: John Diffley (The Francis Crick Institute)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity, and onset and progression of malignancy.

    Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.

    Thursday, April 28, 2016 | 9:00 AM - 5:00 PM

    Epigenetics: Cancer and Beyond

    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
    Speakers: Michael Elowitz (California Institute of Technology), Eric Campeau (Zenith Epigenetics), Ewelina Kulikowski (Resverlogix Corp), Keiko Ozato (National Institute of Child Health and Human Development), Roberto Pili (Indiana University School of Medicine), Patrick Trojer (Constellation), Christopher Vakoc (Cold Spring Harbor Laboratory), Daniel Vitt (4SC AG)

    Epigenetic abnormalities are a recognized contributing factor in tumorigenesis and other diseases. This symposium describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetics marks.

  • Publications 

    eBriefing

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    This eBriefing covers the latest research on pediatric cancers.

    eBriefing

    Epigenetics: Cancer and Beyond

    Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.

    Volume 1375

    eBriefing

    Advances in Human Microbiome Science: Gut–Brain Interaction

    Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)

    This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.